Skip to main content
Europe 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Wednesday, May 10, 2023
  • 08:00 – 18:00 CEST
    Registration Open
  • 09:00 – 16:00 CEST
    IVDR Rollout 2023: Innovation vs Legacy: How to define a Clinical Evidence Strategy for an established analyte/marker or technology versus a novel product.
  • 09:00 – 16:00 CEST
    PMCF Workshop: how to collect valuable data and use it to your benefit?
  • 09:00 – 16:00 CEST
    Risk Management Workshop
  • 09:00 – 16:00 CEST
    UDI / EUDAMED Workshop
  • 09:00 – 16:00 CEST
    Workshop: Be ready for EU CTR: Strategy, Systems and Lessons Learned
  • 09:00 – 16:00 CEST
    Workshop: Global Regulatory CMC Strategies and Challenges for Biologicals
  • 10:30 – 11:00 CEST
    Workshop Coffee Break
  • 16:30 – 18:30 CEST
    Opening Plenary Session: Leveraging our joint clinical data: the new frontier - a debate on our dreams!
  • 18:30 – 19:30 CEST
    Opening Reception
  • Thursday, May 11, 2023
  • 08:00 – 09:00 CEST
    Live LInkedin Profile Feedback Session
  • 08:00 – 18:00 CEST
    Registration Open
  • 08:30 – 17:45 CEST
    Poster Viewing & Voting
  • 09:00 – 10:00 CEST
    Data Security & Digital Health: Medical Devices, IVDs and the Increasing EU Regulation of Health Data
  • 09:00 – 10:00 CEST
    IVDR Transition: Quo Vadis? – the current reality
  • 09:00 – 10:00 CEST
    MDCG 2022-14: Game-Changer or 'Shopping List' for MDR Implementation?
  • 09:00 – 10:00 CEST
    Will the Revision of the EU general pharmaceuticals legislation deliver a world-class, future-proof medicines regulatory system for Europe? (Part 1)
  • 10:00 – 10:30 CEST
    Chapter/LNG Meet and Greets
  • 10:00 – 10:30 CEST
    Presenters at Posters
  • 10:00 – 10:30 CEST
    Refreshment Break in Exhibit Area
  • 10:30 – 11:30 CEST
    Clinical Evaluation: Measurable Outcome Parameters: Much More Than a Requirement for an MDR-Complaint CER
  • 10:30 – 11:30 CEST
    IMDRF- latest developments and future perspectives
  • 10:30 – 11:30 CEST
    Supply Chain
  • 10:30 – 11:30 CEST
    Will the Revision of the EU general pharmaceuticals legislation deliver a world-class, future-proof medicines regulatory system for Europe? (Part 2)
  • 11:45 – 12:45 CEST
    Clinical assessment: how to minimize the questions from your Notified Body
  • 11:45 – 12:45 CEST
    Recent developments in UK regulations for IVDs: implications for EU manufacturers.
  • 11:45 – 12:45 CEST
    Use of The Innovative Licensing and Access Pathway (ILAP) for an AAV Gene Therapy
  • 11:45 – 12:45 CEST
    Using TPLC and GMLP as Your Lighthouse, When Sailing Blind Among AI Icebergs
  • 12:45 – 13:45 CEST
    Lunch, Exhibits, Posters
  • 13:00 – 13:30 CEST
    Sponsored Presentation
  • 13:45 – 14:45 CEST
    AI/machine learning based-medical software: case studies on model development and regulatory compliance
  • 13:45 – 14:45 CEST
    CDx or Not CDx, That is The Question - The Impact of the Clinical Trial Regulation on Tests Used in Pharma Studies and Whether and How the IVDR Applies
  • 13:45 – 14:45 CEST
    Designing Training for an Evolving Regulatory Environment
  • 13:45 – 14:45 CEST
    MDR Art. 117 for Combination Products After 2 years. Still the same? State of Play from EMA, NB and Industry
  • 15:00 – 16:00 CEST
    IVDR – what are the implications for in-house in vitro devices for stakeholders and practical steps for implementation
  • 15:00 – 16:00 CEST
    Medical device regulation in international perspective: EU IMDRF Chair in 2023
  • 15:00 – 16:00 CEST
    Regulatory Policies and Guidelines – Are These Enabling Timely Development of Orphan Medicines Globally?
  • 15:00 – 16:00 CEST
    Responsibilities and Liabilities in an Interconnected World
  • 16:00 – 16:45 CEST
    Presenters at Posters
  • 16:00 – 16:45 CEST
    Refreshment Break in Exhibit Area
  • 16:05 – 16:35 CEST
    Sponsored Presentation
  • 16:45 – 17:45 CEST
    Conformity Assessment of Class D Devices: What is the Current Status?
  • 16:45 – 17:45 CEST
    Expert Advisory Panel - What Have we Learned?
  • 16:45 – 17:45 CEST
    Global Regulatory CMC Strategies and Challenges
  • 16:45 – 17:45 CEST
    Regulation Changes: Incentives for Pediatric Medical Devices in the US and Japan. Implications for the EU.
  • 18:30 – 21:00 CEST
    Networking Dinner – Kanarie Club
  • Friday, May 12, 2023
  • 08:00 – 16:30 CEST
    Registration Open
  • 08:30 – 16:00 CEST
    Poster Viewing
  • 09:00 – 10:15 CEST
    Conversations That Matter: Interactions with Health Authorities
  • 10:15 – 10:45 CEST
    Chapter/LNG Meet and Greets
  • 10:15 – 10:45 CEST
    Presenters at Posters
  • 10:15 – 10:45 CEST
    Refreshment Break in Exhibit Area
  • 10:45 – 11:45 CEST
    Device Lifetime and Lifecycle Management
  • 10:45 – 11:45 CEST
    EMA’s PRIME Scheme in review. Findings and Lessons Learnt
  • 10:45 – 11:45 CEST
    Medical Device Software: Top Recurrent Regulatory Deficiencies from Both FDA and Notified Bodies
  • 10:45 – 11:45 CEST
    Meeting the EU IVDR PMS and PMPF provisions – setting up an effective PMS/PMPF and reporting system
  • 12:00 – 13:00 CEST
    Real World Evidence...What Could Possibly go Wrong? A Clinician's Perspective
  • 12:00 – 13:00 CEST
    Research Use Only (RUO): What does this mean for legacy devices and product development of new in vitro diagnostics under the IVDR?
  • 12:00 – 13:00 CEST
    UKCA: challenges and opportunities
  • 12:00 – 13:00 CEST
    Will Data-Driven Regulatory Science Stimulate Innovation and Initiate a New Regulatory Paradigm?
  • 13:00 – 14:00 CEST
    Lunch, Exhibits, Posters
  • 13:15 – 13:45 CEST
    Sponsored Presentations
  • 14:00 – 15:00 CEST
    Due Diligence: Critical Importance of Regulatory & Quality to Support Company or Product Acquisitions
  • 14:00 – 15:00 CEST
    Software and Cybersecurity Specific Requirements - Challenges for Regulatory Compliance and Testing Approaches
  • 14:00 – 15:00 CEST
    Standards & Compliance: Updates on ‘Sustainable’ Medical Devices
  • 14:00 – 15:00 CEST
    Strategic approaches in pregnancy and paediatrics: Is it time for a paradigm shift?
  • 15:00 – 15:30 CEST
    Presenters at Posters
  • 15:00 – 15:30 CEST
    Refreshment Break in Exhibit Area
  • 15:30 – 16:30 CEST
    Closing Panel: Impact of MDCG 2022-14 Position Paper on NB Capacity Since Publication
  • 15:30 – 16:30 CEST
    Cybersecurity: Compliantly Securing our Healthcare Future
  • 15:30 – 16:30 CEST
    European Expedited Approval Pathways in a Global Context
  • 15:30 – 16:30 CEST
    MDCG22-14 Panel: Will IVDR Implementation Benefit From MDCG 2022-14 and if so, How ?
  • 16:30 – 17:00 CEST
    Closing Remarks & Farewell Toast